Large review building insight on outcomes of surgical mesh removal
May 23rd 2012Findings from a study by UCLA urologists of all patients who underwent surgical mesh removal over a 6-year period will hopefully help surgeons who care for these patients with their management decisions and counseling efforts, researchers say.
Flexible-dose antimuscarinic decreases nocturnal urgency episodes
May 23rd 2012In treating nocturia related to urgency, flexible-dose fesoterodine (Toviaz) demonstrates statistical superiority to placebo in several areas, reported researchers from State University of New York Downstate Medical School, Brooklyn.
Internet-marketed PDE-5 inhibitors frequently counterfeit, dangerous
May 23rd 2012Men who order so-called generic Viagra acquired from the Internet are more likely to be ingesting paint, gypsum, rat poison, and a host of other substances found more often in garages than pharmacies, researchers have discovered.
Task Force sticks to its guns on PSA screening; urologists respond strongly, quickly
May 22nd 2012The highly contentious issue of prostate cancer screening heated up during this week's AUA annual meeting when the United States Preventive Services Task Force (USPSTF) announced on Monday that it would not change its grade "D" recommendation on PSA screening for prostate cancer.
Minimally invasive lymph node dissection offers excellent outcomes in testis Ca cases
May 22nd 2012Minimally invasive retroperitoneal lymph node dissection in cases of testicular cancer produces excellent outcomes and reduces length of stay, according to a nationwide study conducted by urologists at the University of California, San Diego. The study compared the minimally invasive procedure to the standard open procedure.
Phase II data: Investigational OAB agent safe, efficacious
May 21st 2012In phase II results presented here yesterday, the investigational beta3-adrenoceptor agonist solabegron yielded statistically significant improvements in symptoms of overactive bladder compared to placebo and was safe and well tolerated, Dutch researchers reported.
Oncologic outcomes equal for robotic, open RP, even in high-risk patients
May 21st 2012In the hands of high-volume surgeons, there is no evidence to suggest that robot-assisted laparoscopic prostatectomy (RALP) results in worse oncologic outcomes than open radical prostatectomy, even for patients with high-risk cancer, according to a retrospective study of patients operated on at a large tertiary care center.
Partial nephrectomy found underused in poorer, sicker patients
May 21st 2012Despite its well-established advantages over radical surgery, partial nephrectomy is not as likely to be used for older, sicker, and poorer patients who are uninsured or rely on Medicare or Medicaid for their health care, researchers from Henry Ford Hospital, Detroit reported here yesterday.
Prostate Ca assay helps distinguish negative biopsy results from occult disease
May 20th 2012MDxHealth SA (Irvine, CA) has announced the launch of ConfirmMDx for Prostate Cancer, an epigenetic assay that helps urologists distinguish patients who have a true-negative prostate biopsy from those who may have occult cancer.
Risk of birth defects higher for ICSI compared with IVF
May 16th 2012In a study identifying the risk of major birth defects associated with different types of assisted reproductive technology, Australian researchers have reported a significantly higher risk of birth defects involving intracytoplasmic sperm injection (ICSI) compared to in vitro fertilization (IVF).
CT's utility following inconclusive abdominal ultrasound varies
May 16th 2012About one-third of computed tomography scans performed following an inconclusive abdominal ultrasound examination have positive findings, according to a recent study. Follow-up scans appear to be most useful in the diagnosis of renal lesions.